Osteoporotic Fractures in the Time of COVID-19

Bhattacharyya, Timothy

doi:10.1002/jbmr.4113

Cited by 4 publications

(6 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vertebral fractures (VFs) are clinically meaningful because impaired pulmonary function is associated with spine deformities, so a potential outcome predictor of COVID-19 infection may be the presence of VF. [ 14 , 15 ] One study reported that the prevalence of VF was much higher as compared with epidemiological data reported in previous studies on general populations. [ 16 ] Thus, it is suggested that morphometric vertebral evaluation should be performed in all suspected COVID-19 patients undergoing chest X-rays.…”

Section: Trend Of Osteoporotic Fracture In Covid-19 Pandemicmentioning

confidence: 96%

The Impact of COVID-19 on the Optimal Management of Osteoporosis

2021

View full text Add to dashboard Cite

Osteoporosis does not take a break while Coronavirus disease 2019 (COVID-19) stunned and overtook everyone's lives. Medical resources were immediately shifted, self-isolation and telemedicine were expanded, ambulatory care services such as bone densitometry and osteoporosis-centered clinics came to a near halt. Progress with fracture prevention has been challenged because osteoporotic fracture with low energy injury is more prevalent even though restriction of people' s movement. Thus we must re-engage with chronic bone health concerns and fracture prevention. This review discusses challenges in management of osteoporosis during the COVID-19 pandemic and reinforces the need to implementing recommendations concerning the importance of bone fragility care with at least those patients who are already treated with antiosteoporotic drugs maintaining their adherence to treatments.

show abstract

Section: Trend Of Osteoporotic Fracture In Covid-19 Pandemicmentioning

confidence: 96%

The Impact of COVID-19 on the Optimal Management of Osteoporosis

2021

View full text Add to dashboard Cite

show abstract

“…Während die Kapazitäten für elektive Aufnahme und Operationen in den Krankenhäusern deutlich reduziert wurden, blieb die Belastung durch Patientinnen und Patienten mit Fragilitätsfrakturen fast unverändert hoch. Während die Aufnahme von Patienten mit einem Alter>60 Jahre, mit Ausnahme von Covid-19 bezogenen Aufnahmen, um 40% abnahm, ging der Anteil der Patientinnen mit Fragilitätsfrakturen nur um 15% und der Anteil der Patientinnen>60 Jahre mit Hüftfrakturen nur um 10% zurück 4 .…”

Section: Entwicklung Von Fragilitätsfrakturen Während Der Pandemieunclassified

Herausforderungen der stationären Versorgung von Fragilitätsfrakturen während der Covid 19-Pandemie – eine Übersicht

2022

View full text Add to dashboard Cite

ZusammenfassungDie Covid-19-Pandemie hat in vielen Bereichen zwangsläufig zu einer Veränderung der gewohnten Strukturen und Abläufe geführt. Auch die Betreuung von Osteoporosepatienten ist davon betroffen – von der Diagnostik bis zur Behandlung, im ambulanten und im stationären Bereich. In einer Literaturrecherche widmeten wir uns der Frage, inwieweit sich die stationäre Versorgung der Osteoporose-Patienten diesbezüglich veränderte.

show abstract

“…The COVID-19 pandemic has disrupted routine medical care globally, with the reallocation of personnel and infrastructure for the acute management of patients suffering from COVID-19 having taken its toll on the treatment of many chronic conditions including musculoskeletal diseases. In addition, social distancing and isolation have led to reduced physical activity and increased sedentary lifestyles, both of which are associated with sarcopenia, osteoporosis, and an increased incidence of fragility fractures [ 2 , 3 ]. In view of the impact of the pandemic on musculoskeletal health, both professional societies and bone specialists have issued recommendations for the optimization of osteoporosis treatment in this era [ 4 •, 5 •, 6 •, 7 •].…”

Section: Introductionmentioning

confidence: 99%

Pros and Cons of Skeletal Medications in the COVID-19 Era

Tsourdi

Drake

2022

Curr Treat Options in Rheum

View full text Add to dashboard Cite

Purpose of Review This review provides an overview regarding osteoporosis therapies during the COVID-19 pandemic. Recent Findings The COVID-19 pandemic has disrupted treatments for osteoporosis and resulted in decreased adherence particularly for parenteral regimens. Osteoporosis medications are safe and effective during the pandemic and should be continued whenever possible. Bisphosphonates have long-lasting effects on bone turnover such that delays in their administration are unlikely to be harmful to skeletal health. In contrast, interruption of denosumab treatment is strongly discouraged because of rapid loss of bone mass and an associated increased risk for rebound vertebral fractures. When osteoanabolic treatments cannot be continued during the pandemic, change to an oral bisphosphonate is advised. Preclinical data suggest possible beneficial effects of some therapies against COVID-19, but require validation in clinical studies. Vitamin D deficiency is associated with a more severe COVID-19 clinical course but data supporting improvements in outcomes with vitamin D supplementation are lacking. Summary The impact of the COVID-19 pandemic on long-term bone health remains unknown but focused interventions to ensure osteoporosis treatment initiation/maintenance should be implemented. Future studies are needed to determine whether osteoporosis medications have an impact on SARS-CoV-2 pathophysiology and COVID-19 clinical outcomes.

show abstract

Osteoporotic Fractures in the Time of COVID-19

Cited by 4 publications

References 2 publications

The Impact of COVID-19 on the Optimal Management of Osteoporosis

The Impact of COVID-19 on the Optimal Management of Osteoporosis

Herausforderungen der stationären Versorgung von Fragilitätsfrakturen während der Covid 19-Pandemie – eine Übersicht

Pros and Cons of Skeletal Medications in the COVID-19 Era

Contact Info

Product

Resources

About